Zetia and Niaspan

Links shared publicly online about this topic

Niaspan tops Zetia in new setback for Merck drug | Reuters

reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitationsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on November 15, 2009 at 11:13 pm By:

HealthyHeart4U low sodium foods Health Business

Niaspan tops Zetia in new setback for Merck drug - Reuters http://bit.ly/1A1zvP

3 years ago...

UPDATE 2-Niaspan tops Zetia in new setback for Merck drug | Reuters

reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitationsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on November 16, 2009 at 12:44 am By:

HealthyHeart4U low sodium foods Health Business

UPDATE 2-Niaspan tops Zetia in new setback for Merck drug - Reuters http://bit.ly/oIV29

3 years ago...

UPDATE 3-Niaspan tops Zetia in new setback for Merck drug | Reuters

reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitationsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on November 16, 2009 at 2:27 am By:

Health_Feed Health Feed Health News

UPDATE 3-Niaspan tops Zetia in new setback for Merck drug - Reuters http://ow.ly/161V5K

3 years ago...

UPDATE 2-Niaspan tops Zetia in new setback for Merck drug | Reuters

reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitationsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on November 15, 2009 at 11:39 pm By:

reutersBenHir Ben Hirschler Health Communicator

Niaspan vs Zetia trial a blow for Merck's cholesterol business, but maybe not a knock-out one http://tinyurl.com/ylzuy6v #AHA2009

3 years ago...

Zetia in the news again

theheart.org — “Wall Street is forecasting a win for extended-release niacin, but one clinician says the results do not mean a bust for Vytorin. Instead, he says, the results add to the existing literature that lowering LDL and raising HDL cholesterol contribute independently to cardiovascular disease risk.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on August 19, 2009 at 6:47 pm By:

theheartorg Shelley Wood Cardiology

heartwire: Wall Street predicting win for extended-release niacin, but results not in yet http://bit.ly/4AJK0h

3 years ago...

RPT-UPDATE 3-Niaspan tops Zetia in new setback for Merck drug | Reuters

reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitationsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on November 16, 2009 at 2:31 pm By:

Health_Feed Health Feed Health News

RPT-UPDATE 3-Niaspan tops Zetia in new setback for Merck drug - Reuters http://ow.ly/1621xi

3 years ago...

Niaspan May Have Outperformed Zetia in a Recently Halted Trial - Health Blog - WSJ

urlborg.com — “Several analysts are reporting that Niaspan outperformed Zetia in a recently halted trial.View full resource at urlborg.com

  • View Related
  • Share

Most Recently Shared on August 18, 2009 at 5:46 pm By:

Questions raised about Zetia in new study

healthcentral.com — “Questions raised about Zetia in new studyView full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on November 17, 2009 at 9:42 pm By:

HeartsHealth Heart Health Health News

CholesterolNetwork: Questions raised about Zetia in new study http://bit.ly/32p4ld Full http://bit.ly/nk8J0

3 years ago...

Merck cholesterol scrips drop as Niaspan rises - FiercePharma

fiercepharma.com — “Last week, all eyes were on Merck's cholesterol drugs. How did Zetia do in that much-anticipated study pitting it against Abbott Laboratories' Niaspan treatment? Well, the American Heart Association... Read more...View full resource at fiercepharma.com

  • View Related
  • Share

Most Recently Shared on November 25, 2009 at 7:09 pm By:

Merck Statement on Zetia Mess Is a Masterpiece of Spin | BNET Pharma Blog | BNET

industry.bnet.com — “You might be forgiven for thinking that Abbott Labs (ABT)’s Niaspan trounced Merck (MRK)’s Zetia in a trial known as “Arbiter 6 HALTView full resource at industry.bnet.com

  • View Related
  • Share

Most Recently Shared on November 16, 2009 at 6:02 pm By:

richmeyer Rich Meyer Health Executive

Merck Statement on Zetia Mess Is a Masterpiece of Spin http://bit.ly/1arCgI

3 years ago...

New Study Raises New Questions About Cholesterol Drug Zetia - Drugs.com MedNews

drugs.com — “A new study raises more questions about ezetimibe (Zetia), a drug used by millions of Americans in tandem with statins to lower LDL, or bad, cholesterol. The trView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on November 16, 2009 at 6:10 pm By:

drugscom Drugs.com Health Site

New Study Raises New Questions About Cholesterol Drug Zetia - http://bit.ly/ufFTI

3 years ago...

New Study Raises New Questions About Cholesterol Drug Zetia - US News and World Report

health.usnews.com — “It was found less effective than extended-release niacin, or NiaspanView full resource at health.usnews.com

  • View Related
  • Share

Most Recently Shared on November 16, 2009 at 3:32 pm By:

Health_Feed Health Feed Health News

New Study Raises New Questions About Cholesterol Drug Zetia - U.S. News & World Report http://ow.ly/1622kj

3 years ago...

Study Raises New Questions About Cholesterol Drug Zetia - myOptumHealth

myoptumhealth.com — “Read the news article Study Raises New Questions About Cholesterol Drug Zetia at www.myOptumHealth.comView full resource at myoptumhealth.com

  • View Related
  • Share

Most Recently Shared on November 16, 2009 at 12:08 pm By:

myOptumHealth myOptumHealth.com Health Site

New Study Raises New Questions About Cholesterol Drug Zetia: It was found less effective than extended-release niac... http://bit.ly/28oBWa

3 years ago...

How does Zetia and niacin affect the carotid intima-media thickness (CIMT)? | KevinMD.com

kevinmd.com — “By a margin of 0.014 mm in carotid intima-media thickness (CIMT), extended-release niacin (Niaspan) demonstrated superiority over ezetimibe (Zetia) as an add-on for high risk patients on long term statin therapy.View full resource at kevinmd.com

  • View Related
  • Share

Most Recently Shared on November 22, 2009 at 8:02 pm By:

strataderm Strataderm for Scars Pharma and Health Social Media

RT @tweetmeme How does Zetia and niacin affect the carotid intima-media thickness (CIMT)? | KevinMD.com http://bit.ly/8RsbEa

3 years ago...

Merck’s Cholesterol Pill Woes May Intensify on Loss to Abbott’s Niaspan

industry-news.org — “By Shannon Pettypiece Nov. 16 (Bloomberg) -- A finding that Merck & Co.’s cholesterol pills Vytorin and Zetia didn’t reopen clogged arteries as well as Abbott Laboratories ’ Niaspan has set off a medical debate on heart treatment strategies. In the trial, researchers reported finding a reduction in the thickness of artery walls in patients given Niaspan, while those on Zetia had no change. Artery thickness is believed to be a predictor of risk in heart attack and stroke because it restrictView full resource at industry-news.org

  • View Related
  • Share

Most Recently Shared on November 16, 2009 at 9:32 pm By:

Resultsfitness Tammi Jacobs Health Professional

Merck's Cholesterol Pill Woes May Intensify on Loss to Abbott's ... http://bit.ly/1VSFXb

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390